Stockscreener 앱 받기
4.2911
0.94%
0.0511
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism - Investing News Network
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, I - The National Law Review
2026-07-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Stockholders to Connect - ACCESS Newswire
AQST News | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
SEC Form S-3 filed by Aquestive Therapeutics Inc. - Quantisnow
Form S-3 Aquestive Therapeutics Inc For: 26 June By Investing.com - Investing.com India
Aquestive Therapeutics | S-3: Registration statement for specified transactions by certain issuers - Moomoo
AQST Stock Price and Chart — NASDAQ:AQST - TradingView
Cantor Fitzgerald Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Aquestive Therapeutics, Inc. Actuals & Estimates (NASDAQ:AQST) - TradingView
symbol__ Stock Quote Price and Forecast - CNN
AQST Forecast — Price Target — Prediction for 2027 - TradingView
LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeut - The National Law Review
Aquestive Therapeutics Inc (AQST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aquestive Therapeutics director Julie Krop sells $125k in stock By Investing.com - Investing.com Nigeria
Form 4 Aquestive Therapeutics Inc For: 24 June By Investing.com - Investing.com Australia
Aquestive Therapeutics director Julie Krop sells $125k in stock - Investing.com
Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Investors to Reach Out - ACCESS Newswire
Form 144 Aquestive Therapeutics For: 23 June By Investing.com - Investing.com Australia
Aquestive Therapeutics (AQST) reports Q1 loss, beats revenue estimates - MSN
2026-06-23 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Investors to Reach Out | NDAQ:AQST | Press Release - Stockhouse
Does US manufacturing give drugmakers a speed edge? - Pharma Voice
Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Connect - ACCESS Newswire
AQUESTIVE THERAPEUTICS INC (AQST) Stock Chart - ChartMill
Aquestive Therapeutics (NYSE:AQST): What Insider Activity Reveals About Corporate Confidence - Kalkine Media
Have Aquestive Therapeutics Insiders Been Selling Stock? - simplywall.st
Aquestive Therapeutics Inc (AQST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aquestive Therapeutics Inc (AQST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aquestive Therapeutics Inc (AQST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aquestive Therapeutics Inc (AQST) Institutional Confidence - TradingKey
Aquestive Therapeutics Inc (AQST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aquestive Therapeutics Inc (AQST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aquestive Therapeutics Inc (AQST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aquestive Therapeutics CEO sells $104,010 in company stock By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO sells $104,010 in company stock - Investing.com UK
Insider Sell: Aquestive Therapeutics Inc (AQST) President and CE - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-06-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Krop Julie - Moomoo
Aquestive (AQST) awards Abigail Jenkins 50,500 stock options at $3.99 - Stock Titan
Aquestive Therapeutics (AQST) director receives 50,500 stock options grant - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
AQST: FDA progress, global expansion, and all proposals passed with strong shareholder support - TradingView
0.71%
1.95%
자본화:
|
볼륨(24시간):